Doses vaccinated in China
Countries that have approved vaccine for emergency use
Foreign order quantity
as of August 31, 2021
On August 30, 2021, the first batch of 567,600 doses of COVID-19 vaccine supplied by Sinovac to COVAX arrived in Algiers, capital of Algeria.
On August 29, 2021, Cuba began to vaccinate some of its citizens with China's Sinopharm COVID-19 vaccine.
On August 28, 2021, the first batch of COVID-19 vaccine from China’s Sinopharm company arrived in Singapore.
On August 26, 2021, Mexico's Federal Commission for Protection Against Health Risks (Cofepris) issued a notice that approved the COVID-19 vaccines produced by Sinopharm for emergency use in the country.
Nigeria's regulatory authorities have approved the emergency use of COVID-19 vaccines developed by China’s Sinopharm in the country, health officials said on August 24, 2021.
On August 23, 2021, the Egyptian Drug Authority announced that it has issued an emergency license for the localized production of China’s Sinovac vaccines.
On August 11, 2021, the first batch of 1 million doses of China’s Sinopharm COVID-19 vaccine under the COVAX program arrived in Pakistan, making it the first country to receive China's COVID-19 vaccine through COVAX.
On August 10, 2021, the first batch of over 1.7 million doses of COVID-19 vaccine provided by China to Bangladesh via the COVAX Facility arrived in Dhaka, the capital of Bangladesh.
South Africa has approved the use of the COVID-19 vaccine developed by China’s Sinovac in the country's COVID-19 vaccine program, the country's health minister Joe Phaahla announced on August 6, 2021.
On July 27, 2021, the first batch of China’s Sinopharm COVID-19 vaccine arrived in El Salvador.
On July 26, 2021, UNICEF signed a long-term agreement with Sinovac on behalf of the COVID-19 Vaccine Implementation Initiative (COVAX).
From July 22 to 24, 2021, a new batch of 2 million doses of COVID-19 vaccine donated to Myanmar by China arrived at Yangon International Airport in three batches.
On July 16, 2021, Malaysia's Health Minister Noor Hisham announced that the country's Drug Regulatory Authority has approved the conditional registration of the COVID-19 vaccine developed by China's Sinopharm for emergency use.
Sri Lanka's National Medicines Regulatory Authority has approved China's Sinovac COVID-19 vaccine for emergency use in the country, State Minister Jayasumana said on July 16, 2021.
On July 14, 2021, Brazil's National Health Surveillance Agency announced that it has authorized phase-3 clinical trials of a COVID-19 inactivated vaccine independently developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences.
On July 13, 2021, the Papua New Guinea government officially began to vaccinate local people with Chinese vaccines at the Port Moresby General Hospital.
On July 11, 2021, the second batch of COVID-19 vaccines donated to Kyrgyzstan by China arrived at its capital Bishkek.
On July 3, 2021, the South African Health Products Regulatory Authority issued a statement announcing the approval of the COVID-19 vaccines developed by China's Sinovac for emergency use.
On June 21, 2021,a batch of China's CoronaVac COVID-19 vaccines ordered by Tunisia arrived at its Carthage International Airport.
On June 15, 2021, China's Sinopharm vaccine began rolling out at the National Convention Centre in the capital city of Port Vila, Vanuatu.
On June 14, 2021, the fourth batch of COVID-19 vaccines donated to Laos by China arrived at the Vadai International Airport in its capital Vientiane.
On June 10, 2021, a batch of COVID-19 vaccines donated by the Chinese government arrived in Kabul, the capital of Afghanistan.
On June 6, 2021, Bangladesh’s Directorate General of Drug Administration approved the emergency use of the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use in the country.
On June 5, 2021, Nepal's Department of Drug Administration approved the emergency use of the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use in the country.
On May 23, 2021, Chile's President Sebastian Piñera welcomed a shipment of 2.2 million COVID-19 vaccine doses made by Chinese pharmaceutical firm Sinovac at Santiago International Airport.
On May 18, 2021, the second batch of China-donated COVID-19 vaccines arrived in Minsk, the capital of Belarus.
On May 17, 2021, Thailand received 500,000 doses of Sinovac COVID-19 vaccines donated by China.
On May 12, 2021, Bangladesh received 500,000 doses of China's Sinopharm COVID-19 vaccine as a gift in its capital Dhaka.
On May 9, 2021, the second batch of China-donated Sinopharm vaccines arrived in Libreville, the capital of Gabon.
On May 7, 2021, the World Health Organization approved the COVID-19 vaccine developed by China's Sinopharm for emergency use.
On May 2, 2021, Myanmar received 500,000 doses of COVID-19 vaccine donated by China in Yangon International Airport.
On April 30, 2021, Indonesia's Food and Drug Administration issued emergency use authorization for China’s Sinopharm COVID-19 vaccine.
On April 28, 2021, the Bangladeshi government gave the green light to a proposal to produce Chinese Sinopharm COVID-19 vaccines in the country.
On April 26, 2021, the Egyptian Drug Authority announced that the CoronaVac vaccine developed by Chinese pharmaceutical company Sinovac has been given emergency use authorization in Egypt.
On April 26, 2021, Serbia received a new batch of Sinopharm COVID-19 vaccines purchased from China in its capital Belgrade.
On April 24, 2021, a batch of Chinese-manufactured COVID-19 vaccines offered by the Chinese government arrived in Damascus, capital of Syria.
On April 23, 2021, Malaysia's National Pharmaceutical Regulatory Agency granted conditional approval for the COVID-19 vaccine developed by the Chinese pharmaceutical company Sinovac Biotech to be produced locally in Malaysia.
On April 21, 2021, Egyptian Holding Company for Biological Products and Vaccines (VACSERA) and Chinese biopharmaceutical company Sinovac signed an agreement to manufacture Sinovac COVID-19 vaccines in Egypt.
On April 16, 2021, Brazil's National Health Surveillance Agency authorized clinical trials of a new COVID-19 vaccine developed by China's Sichuan Clover Biopharmaceuticals.
On April 13, 2021, the first batch of Sinopharm COVID-19 vaccines donated by China arrived at Sir Seewoosagur Ramgoolam International Airport, Mauritius.
On April 11, 2021, a batch of Sinopharm COVID-19 vaccines donated by China arrived in Honiara, Solomon Islands.
On April 11, 2021, 200,000 doses of Sinopharm COVID-19 vaccine donated by China arrived in Mogadishu, capital of Somalia.
On April 11, 2021, the first batch of Sinopharm COVID-19 vaccines donated by China arrived in Yaounde, capital of Cameroon.
On April 9, 2021, Panamanian health authorities approved the emergency use of the CoronaVac vaccine developed by Chinese pharmaceutical firm Sinovac.
On April 8, 2021, the Drug Regulatory Authority of Pakistan stated that the CoronaVac vaccine developed by Chinese pharmaceutical company Sinovac has been given emergency use authorization for people aged 18 and above.
On April 7, 2021, Chile’s health regulator Instituto de Salud Pública gave its approval for the emergency use of the one-dose COVID-19 vaccine manufactured by Chinese firm CanSino Biologics.
On April 7, 2021, the first batch of COVID-19 vaccines that Ecuador purchased from Chinese pharmaceutical company Sinovac arrived in its capital Quito.
On April 6, 2021, two batches of Sinopharm COVID-19 vaccines donated by China arrived at the Rafic Hariri International Airport in Beirut, Lebanon.
On April 4, 2021, the first batch of the Sinopharm COVID-19 vaccines that Jordan purchased from China arrived in its capital Amman.
On April 3, 2021, Georgia received the first batch of Sinopharm COVID-19 vaccines purchased from China in its capital Tbilisi.
On April 2, 2021, Mongolia received the first batch of COVID-19 vaccines it purchased from China in its capital Ulan Bator, and the handover ceremony was held at Chinggis Khaan International Airport.
On April 1, 2021, Azerbaijan received the first batch of Sinovac COVID-19 vaccines it purchased from China in its capital Baku.
On March 31, 2021, two batches of Chinese COVID-19 vaccines from Sinopharm and CanSino purchased by the Pakistani government were handed over at the Noor Khan Air Base near its capital Islamabad.
On March 31, 2021, a batch of Sinopharm vaccines donated by China arrived at Bandaranaike International Airport in Colombo, capital of Sri Lanka.
On March 28, 2021, El Salvador received the first batch of COVID-19 vaccines from Chinese pharmaceutical company Sinovac.
On March 27, 2021, the first batch of Chinese coronavirus vaccines purchased by Uzbekistan arrived in its capital Tashkent.
On March 26, 2021, a batch of China's Sinopharm COVID-19 vaccines, donated by the Chinese government to Sudan, arrived in its capital Khartoum.
On March 26, 2021, a batch of COVID-19 vaccines Cambodia purchased from China's pharmaceutical company Sinovac Biotech arrived at Phnom Penh International Airport.
On March 25, 2021, Angola received the Chinese government's donation of Sinopharm COVID-19 vaccines, which arrived at Angola's Luanda international airport.
On March 25, 2021, a plane carrying the first batch of CoronaVac vaccines produced by Chinese company Sinovac Biotech arrived in Kiev, the capital of Ukraine.
On March 25, 2021, Tunisia received a batch of COVID-19 vaccines donated by China, which arrived at the Carthage International Airport in the capital Tunis.
On March 24, 2021, the first batch of COVID-19 vaccines and anti-epidemic materials donated by China to the Maldives arrived in its capital Malé.
On March 24, 2021, Mauritania received the Chinese government's donation of Sinopharm COVID-19 vaccines and medical ventilators, which arrived at Nouakchott Oumtounsy International Airport.
On March 24, 2021, the second batch of Sinovac COVID-19 vaccines donated by China to the Philippines arrived in the country’s capital Manila.
On March 22, 2021, China handed over the second batch of COVID-19 vaccine donations to Egypt.
On March 22, 2021, the first shipment of COVID-19 vaccines co-developed by the Institute of Military Medicine under the Chinese Academy of Military Sciences and Chinese biopharmaceutical company CanSino Biologics was packaged in Mexico's Queretaro State, and delivered to a storage site designated by the Mexican government after a handover ceremony.
On March 22, 2021, the National Institute of Pharmacy and Nutrition of Hungary granted China's CanSino vaccine emergency use authorization, Hungarian Chief Medical Officer Cecilia Muller said.
On March 21, 2021, Chinese Ambassador to Benin, Peng Jingtao, and Beninese Health Minister, Benjamin Hounkpatin, welcomed a batch of COVID-19 vaccines developed by the Chinese pharmaceutical company Sinovac at Cardinal Bernadin Gantin International Airport in Cotonou, the economic capital of Benin.
On March 21, 2021, the sixth batch of COVID-19 vaccines produced by China’s Sinovac arrived in Santiago, the capital of Chile.
On March 21, 2021, a batch of China-donated COVID-19 vaccines arrived in Niamey, the capital of Niger.
On March 20, 2021, a new batch of COVID-19 vaccines produced by China’s Sinovac arrived at El Dorado International Airport in Bogota, Colombia.
On March 20, 2021, the second batch of COVID-19 vaccines ordered by Thailand from China's Sinovac arrived in Bangkok.
On March 20, 2021, Sri Lanka's National Medicines Regulatory Authority approved the China-produced Sinopharm COVID-19 vaccine for emergency use in the island country, according to Sri Lankan State Minister of Production, Supply and Regulation of Pharmaceuticals Channa Jayasumana.
On March 19, 2021, a batch of China's Sinopharm vaccines was delivered to Kyrgyzstan, and a donation ceremony was held at the Manas International Airport in its capital Bishkek.
On March 18, 2021, Serbia signed a contract with China's Sinopharm at an online meeting to purchase more of its COVID-19 vaccines, the Serbian president's office confirmed.
On March 18, 2021, a batch of Sinovac COVID-19 vaccines donated by the Chinese government arrived at Djibouti-Ambouli International Airport, in Ambouli town, Djibouti.
On March 17, 2021, Pakistan received the second batch of COVID-19 vaccines donated by the Chinese government at a handover ceremony held at the Noor Khan Air Base near Pakistan's capital Islamabad.
On March 17, 2021, a batch of Sinovac COVID-19 vaccines purchased by the Dominican Republic from China arrived in its capital Santo Domingo, along with a batch of Sinopharm COVID-19 vaccines and injection syringes donated by China.
On March 17, 2021, a Chinese medical aid team arrived in Moroni, the capital city of the Union of the Comoros. A batch of COVID-19 vaccines and medical supplies provided to Comoros by the Chinese government also arrived in Moroni on the same flight.
On March 16, 2021, a batch of China-donated COVID-19 vaccines from Chinese firm Sinovac arrived at the Hosea Kutako International Airport in Namibia's capital Windhoek.
On March 16, 2021, a new batch of CoronaVac vaccines from Chinese pharmaceutical firm Sinovac arrived in Montevideo, Uruguay, along with masks, goggles and other epidemic prevention materials donated by China.
On March 16, 2021, Zimbabwe received the second batch of Sinopharm doses donated by China at Robert Gabriel Mugabe International Airport in its capital Harare, along with additional Sinovac doses commercially procured by the government.
On March 15, 2021, the COVID-19 vaccine developed by China's Sinopharm was approved for emergency use in the Maldives, the Maldives Food and Drug Administration announced at a press conference.
On March 15, 2021, Brazil's Butantan Institute in Sao Paulo delivered a batch of CoronaVac vaccines to the country’s health ministry. Chinese laboratory Sinovac Life Science developed the vaccine and provided semi-finished products to its partner Butantan Institute, whose plant carried out filling and packaging.
On March 15, 2021, Belarus started its COVID-19 vaccination roll-out using COVID-19 vaccines donated by China.
On March 12, 2021, the first batch of China-donated Sinopharm vaccines arrived in Libreville, the capital of Gabon.
On March 12, 2021, a shipment of 300,000 doses of Sinopharm COVID-19 vaccine purchased by Bahrain arrived in the country’s capital Manama.
On March 11, 2021, the second batch of China’s COVID-19 vaccines arrived in Budapest, capital of Hungary.
On March 10, 2021, a batch of Sinopharm COVID-19 vaccines donated by China to the Republic of Congo arrived in its capital Brazzaville.
On March 10, 2021, Ukraine's Deputy Minister of Health Igor Ivashchenko said that the Ministry of Health of Ukraine has decided to approve the registration of the COVID-19 vaccine produced by China’s Sinovac for emergency use in the country.
On March 8, 2021, Mozambique launched its vaccination campaign against COVID-19 in Maputo Central Hospital, with the country's Health Minister Armindo Tiago becoming the first to receive the vaccine provided by China’s Sinopharm.
On March 6, 2021, a batch of COVID-19 vaccines provided by the Chinese government to the government of Turkmenistan arrived in its eastern city of Turkmenabad.
On March 4, 2021, a handover ceremony of Sinopharm COVID-19 vaccines donated by China to Dominica was held at the Dominica-China Friendship Hospital in Roseau, capital of the Caribbean country.
On March 4, 2021, Chinese Ambassador to Egypt Liao Liqiang and the Arab League (AL) Assistant Secretary-General Hossam Zaki attended a reception ceremony for the China-donated COVID-19 vaccines at AL headquarters in Cairo, Egypt.
On March 3, 2021, a batch of Sinopharm COVID-19 vaccines donated by the Chinese government to the Guinean government arrived in Conakry, the capital of Guinea.
On March 3, 2021, a batch of Sinopharm COVID-19 vaccines donated by China to Montenegro arrived in its capital Podgorica.
On March 2, 2021, a shipment of COVID-19 vaccines donated by the Chinese government to the Guyanese government arrived in Georgetown, capital of Guyana.
On March 2, 2021, Malaysia granted approval of conditional registration for emergency use of the COVID-19 vaccine made by Chinese company Sinovac Biotech, the health ministry said.
On March 2, 2021, the first batch of Sinopharm COVID-19 vaccines donated by China to Iraq arrived in its capital Baghdad and was handed over to the Iraqi Ministry of Health.
On March 1, 2021, the Ministry of Innovative Development of Uzbekistan said that the country has registered a China-made recombinant protein COVID-19 vaccine for emergency use and marketing authorization in Uzbekistan.
On February 28, 2021, the first batch of COVID-19 vaccines donated by China to the Philippines arrived at Villamor Air Force Base in its capital Manila.
On February 28, 2021, Thailand started its COVID-19 vaccination roll-out of at-risk groups using China’s Sinovac vaccine. The first shots went to Deputy Prime Minister and Public Health Minister Anutin Charnvirakul and four other Cabinet members.
On February 27, 2021, the first batch of semi-finished COVID-19 vaccines ordered by Malaysia from the Chinese biopharmaceutical company Sinovac Biotech arrived at Kuala Lumpur International Airport.
On February 25, 2021, the first batch of Sinovac COVID-19 vaccines purchased by the Uruguayan government arrived in Montevideo, the capital of Uruguay. This is the first batch of COVID-19 vaccines to be received in the country.
On February 25, 2021, the Ecuadorian government said it had negotiated the purchase of 2 million doses of COVID-19 vaccines with Chinese pharmaceutical company Sinovac, Health Minister Juan Carlos Zevallos said.
On February 24, 2021, the Government Analyst Food and Drug Administration of Guyana officially approved emergency use of a COVID-19 vaccine developed by Chinese pharmaceutical firm Sinopharm, said Frank Anthony, Health Minister of Guyana.
On February 24, 2021, a donation of Chinese Sinopharm coronavirus vaccines arrived at the Boufarik military airport in Blida, Algeria.
On February 24, 2021, a batch of Sinopharm COVID-19 vaccines donated by China arrived in Maputo, Mozambique.
On February 24, 2021, China's Sinopharm COVID-19 vaccines arrived in Santa Cruz, Bolivia.
On February 24, 2021, Namibian President Hage Geingob lauded China and other countries that have extended help with donations in the form of COVID-19 vaccines to Namibia and other African countries to help with the fight against the devastating pandemic.
On February 24, 2021, Hungary started using China's Sinopharm vaccine against the coronavirus, Prime Minister Viktor Orban said in a Facebook video message.
On February 23, 2021, Singapore received its first batch of the COVID-19 vaccine made by China's Sinovac Biotech.
On February 23, 2021, the Dominican Republic received the first batch of the COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac. Vice President Raquel Pena and several senior officials received the shipment at the airport.
On February 23, 2021, a batch of Sinopharm COVID-19 vaccines provided by China for Egypt arrived in Cairo International Airport.
On February 22, 2021, the Food and Drug Administration of Thailand approved Chinese biopharmaceutical firm Sinovac Biotech's COVID-19 vaccine for emergency use.
On February 22, 2021, the Philippines officially approved the emergency use of China's Sinovac COVID-19 vaccine, according to the country's Food and Drug Administration.
On February 22, 2021, Sinopharm COVID-19 vaccines donated by China arrived at the Chinggis Khaan International Airport in Ulan Bator, Mongolia.
On February 21, 2021, the Argentine government officially approved the emergency use of an inactivated COVID-19 vaccine developed by Chinese pharmaceutical firm Sinopharm, according to a resolution signed by the country's Minister of Health Carla Vizzotti.
On February 20, 2021, the first shipment of China’s Sinovac vaccine arrived in the Mexican capital Mexico City. Mexico's government arranged for it to arrive in Ecatepec, a city in central State of Mexico that lies on the outskirts of the capital.
On February 20, 2021, the first batch of vaccines from Chinese pharmaceutical company Sinovac arrived in Bogota, Colombia. Colombian President Ivan Duque welcomed the arrival of the shipment at a news conference at the site.
On February 19, 2021, the COVID-19 vaccine aid provided to Belarus by the Chinese government arrived in the country. Belarusian Health Minister Dmitry Pinevich expressed gratitude to the Chinese government for providing the vaccines.
On February 18, 2021, the Zimbabwean government began rolling out its COVID-19 inoculation program following the arrival of the Sinopharm vaccines donated by the Chinese government in Harare on February 15. It was the first batch of COVID-19 vaccine received by the country.
On February 17, 2021, the Department of Drug Administration of Nepal granted approval to the COVID-19 vaccine developed by China's Beijing Institute of Biological Products Co. Ltd, under Sinopharm for emergency use in the country.
On February 10, 2021, a batch of China-donated Sinopharm COVID-19 vaccines arrived in Malabo, Equatorial Guinea. Teodoro Nguema Obiang Mangue, Vice President of Equatorial Guinea, received his first shot of the Chinese vaccine on February 11.
On February 10, 2021, the Ministry of Foreign Affairs of Mexico said that the Federal Commission for the Protection against Sanitary Risks had authorized the emergency use of COVID-19 vaccines developed by Chinese pharmaceutical firms Sinovac Biotech and CanSino Biologics.
On February 5, 2021, the State Agency for Medicines and Health Technologies of Bolivia officially approved the registration and marketing of Chinese pharmaceutical firm Sinopharm's COVID-19 vaccine.
On February 3, 2021, Colombia announced that the country's National Food and Drug Surveillance Institute had authorized the emergency use of COVID-19 vaccines developed by Chinese firm Sinovac Biotech.
On January 29, 2021, Hungary approved the use of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group, becoming the European Union's first member to approve a Chinese COVID-19 vaccine.
On January 26, 2021, Peru approved the emergency use of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On January 22, 2021, the Health Ministry of Morocco said in a statement that Morocco had approved the emergency use of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On January 20, 2021, the Public Health Institute of Chile approved the emergency use of the COVID-19 vaccine developed by Chinese firm Sinovac Biotech.
On January 19, 2021, the Iraqi Ministry of Health said that the Iraqi National Board for Selection of Drugs approved the emergency use of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On January 19, 2021, Serbian government officials, including Health Minister Zlatibor Loncar and Defence Minister Nebojsa Stefanovic, received the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On January 18, 2021, Peruvian Health Minister Pilar Mazzetti reported that Peru has signed an agreement for air transport of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group, with 1 million vaccines available at the initial stage.
On January 18, 2021, Director of the Algerian State Health Security Agency Kamel Senhadji said that the Chinese COVID-19 vaccines that Algeria plans to buy are safe and effective.
On January 18, 2021, the Drug Regulatory Authority of Pakistan approved the COVID-19 vaccine developed by Sinopharm's China National Biotec Group for emergency use.
On January 18, 2021, Azerbaijani Health Minister Ogtay Shiraliyev took the first shot of the COVID-19 vaccine developed by Chinese company Sinovac Biotech, marking the beginning of mass vaccination against COVID-19 in the country.
On January 17, 2021, Brazil's Health Regulatory Agency approved the emergency use of the CoronaVac vaccine developed by Chinese company Sinovac Biotech. Brazil started nationwide vaccination on the following day.
On January 16, 2021, Serbian resident Aleksandar Vucic went to Belgrade's airport to receive delivery of 1 million doses of Sinopharm's COVID-19 vaccine.
On January 16, 2021, Turkish Vice President Fuat Oktay received the first dose of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group at the Ankara City Hospital.
On January 14, 2021, Hungary Prime Minister's chief of staff Gergely Gulyas told a briefing that Hungary had reached a deal with China's Sinopharm to buy its COVID-19 vaccines, with the first shipment including up to 1 million doses.
On January 14, 2021, Philippine presidential spokesperson Harry Roque told an online briefing, "I will choose the two Chinese brands, [Sinopharm and Sinovac], because they are inactivated vaccines."
On January 14, 2021, Turkish President Recep Tayyip Erdogan received his first dose of the COVID-19 vaccine developed by Chinese company Sinovac Biotech.
On January 13, 2021, Senegal Health Minister Abdoulaye Diouf Sarr said that Senegal is in talks to buy at least 200,000 doses of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On January 13, 2021, Turkey approved the emergency use of the COVID-19 vaccine developed by Chinese company Sinovac Biotech. Turkish Health Minister Fahrettin Koca received the first shot of the vaccine.
On January 13, 2021, Indonesia's President Joko Widodo received the first dose of Chinese company Sinovac Biotech's COVID-19 vaccine at the State Palace.
On January 12, 2021, Malaysia's Pharmaniaga Berhad signed an agreement with Chinese company Sinovac Biotech to purchase ready-to-fill COVID-19 vaccines and later to manufacture the vaccine domestically. Pharmaniaga will carry out a fill-and-finish process for the vaccine in Malaysia, and will subsequently enter into local manufacturing under license from Sinovac for its technology and know-how.
On January 10, 2021, Jordan's Prime Minister Bisher al-Khasawneh and several other members of the government received COVID-19 vaccines manufactured by Sinopharm's China National Biotec Group.
On January 10, 2021, Seychelles President Wavel Ramkalawan received the first shot of the COVID-19 vaccine manufactured by Sinopharm's China National Biotec Group.
On January 6, 2021, Peruvian President Francisco Sagasti announced that Peru has signed an agreement with Chinese pharmaceutical firm Sinopharm to acquire its COVID-19 vaccine.
On January 5, 2021, the Ministry of Health and Prevention of the United Arab Emirates (UAE) announced that UAE plans to start manufacturing Sinopharm's COVID-19 vaccines and also buy millions of doses from the company.
On January 3, 2021, Indonesia started distributing the COVID-19 vaccine developed by Chinese company Sinovac Biotech to all its 34 provinces.
On January 3, 2021, the World Health Organization said that Thailand is expected to buy two million doses of COVID-19 vaccine developed by Chinese company Sinovac Biotech.
On January 2, 2021, Egyptian Health Minister Hala Zayed said that the COVID-19 vaccine developed by Sinopharm's China National Biotec Group has been officially licensed for emergency use in Egypt.
On December 30, 2020, the Ukrainian Health Ministry signed a contract to buy over 1.9 million doses of COVID-19 vaccine manufactured by Chinese company Sinovac Biotech.
On December 28, 2020, officials confirmed that members of the Philippine President's security team have received COVID-19 vaccines developed by Sinopharm's China National Biotec Group.
On December 24, 2020, Morocco announced it has acquired COVID-19 vaccines developed by Sinopharm's China National Biotec Group.
On December 16, 2020, Bahrain's King Hamad received a COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On December 13, 2020, Bahrain approved the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On December 10, 2020, the Mexican Health Ministry signed an agreement to buy 35 million doses of Chinese firm CanSino Biologics' COVID-19 vaccine.
On December 9, 2020, the United Arab Emirates issued government approval of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On November 3, 2020, Vice President and also the Prime Minister of the United Arab Emirates Sheikh Mohammed Bin Rashid Al Maktoum received a COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On September 16, 2020, Turkey began phase 3 clinical trial of the COVID-19 vaccine developed by Chinese company Sinovac Biotech.
On September 16, 2020, Bahrain's Crown Prince Salman bin Hamad al-Khalifa received a COVID-19 vaccine injection as part of the phase 3 trials of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On August 20, 2020, Peru approved phase 3 clinical trials of the COVID-19 vaccine developed by Sinopharm's China National Biotec Group.
On August 11, 2020, Indonesia began phase 3 clinical trials of the COVID-19 vaccine developed by Chinese company Sinovac Biotech.
On July 21, 2020, Brazil began phase 3 clinical trials of the COVID-19 vaccine developed by Chinese company Sinovac Biotech.
On June 23, 2020, the phase 3 clinical trials of the COVID-19 inactivated vaccine developed by Sinopharm's China National Biotec Group were officially launched in the United Arab Emirates. The UAE Minister of Health and Prevention issued an approval certificate.